AFP and hepatocellular carcinoma: AFP is the most widely used serum marker for HCC in the world, whereas the deepening of research identified that many HCC patients do not show elevated AFP, which means that the clinical diagnosis of HCC (especially negative AFP) cannot rely solely on AFP [7].